Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Several technologies for hemoglobinopathies are being transferred to commercial partners
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Experts urge early detection & better access to care
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Subscribe To Our Newsletter & Stay Updated
